Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses
2007

Breast Cancer and Cancer-Testis Antigens: A Potential Vaccine Target

Sample size: 82 publication Evidence: moderate

Author Information

Author(s): Taylor Mark, Bolton Louise M, Johnson Peter, Elliott Tim, Murray Nick

Primary Institution: University of Southampton

Hypothesis

What is the frequency of expression of cancer-testis antigens (CTAGs) in breast cancer?

Conclusion

More than two-thirds of breast cancers would be covered by a vaccine directed against just three CTAGs.

Supporting Evidence

  • 93% of tumours in the first series expressed at least one CTAG.
  • 62% expressed the single antigen CTAG1.
  • 80% of tumours in the second series expressed at least one CTAG.

Takeaway

Most breast cancers have special proteins called CTAGs that a vaccine could target to help the immune system fight the cancer.

Methodology

Breast tumours were collected and screened for expression of various CTAGs using cDNA analysis.

Limitations

The study did not analyze the HLA status of the individuals from whom the tumour specimens were derived.

Participant Demographics

Tumour samples were obtained from individuals undergoing surgery for primary invasive breast cancer.

Digital Object Identifier (DOI)

10.1186/bcr1749

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication